BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35361785)

  • 1. Developing symptom clusters: linking inflammatory biomarkers to depressive symptom profiles.
    Franklyn SI; Stewart J; Beaurepaire C; Thaw E; McQuaid RJ
    Transl Psychiatry; 2022 Mar; 12(1):133. PubMed ID: 35361785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdiagnostic biomarker approaches to mental health disorders: Consideration of symptom complexity, comorbidity and context.
    McQuaid RJ
    Brain Behav Immun Health; 2021 Oct; 16():100303. PubMed ID: 34589795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA).
    Duivis HE; Vogelzangs N; Kupper N; de Jonge P; Penninx BW
    Psychoneuroendocrinology; 2013 Sep; 38(9):1573-85. PubMed ID: 23399050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and the dimensions of depression: A review.
    Majd M; Saunders EFH; Engeland CG
    Front Neuroendocrinol; 2020 Jan; 56():100800. PubMed ID: 31654681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deriving psychiatric symptom-based biomarkers from multivariate relationships between psychophysiological and biochemical measures.
    Stout DM; Simmons AN; Nievergelt CM; Minassian A; Biswas N; Maihofer AX; Risbrough VB; Baker DG
    Neuropsychopharmacology; 2022 Dec; 47(13):2252-2260. PubMed ID: 35347268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom clusters in patients with breast cancer receiving radiation therapy.
    Chow S; Wan BA; Pidduck W; Zhang L; DeAngelis C; Chan S; Yee C; Drost L; Leung E; Sousa P; Lewis D; Lam H; Chow R; Lock M; Chow E
    Eur J Oncol Nurs; 2019 Oct; 42():14-20. PubMed ID: 31446259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affective and somatic symptom clusters in depression and their relationship to treatment outcomes in the STAR*D sample.
    Collins KA; Eng GK; Tural Ü; Irvin MK; Iosifescu DV; Stern ER
    J Affect Disord; 2022 Mar; 300():469-473. PubMed ID: 34952119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Associations Between C-Reactive Protein and Mood and Anxiety Symptoms in Adolescents.
    Liu Q; Ely BA; Simkovic S; Alonso CM; Gabbay V
    J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):404-410. PubMed ID: 34166062
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptom profiles of women at risk of mood disorders: A latent class analysis.
    Weiss SJ; Flynn H; Christian L; Hantsoo L; di Scalea TL; Kornfield SL; Muzik M; Simeonova DI; Cooper BA; Strahm A; Deligiannidis KM
    J Affect Disord; 2021 Dec; 295():139-147. PubMed ID: 34450523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients.
    Low CA; Bovbjerg DH; Jenkins FJ; Ahrendt SA; Choudry HA; Holtzman MP; Jones HL; Pingpank JF; Ramalingam L; Zeh HJ; Zureikat AH; Bartlett DL
    Brain Behav Immun; 2014 Nov; 42():65-8. PubMed ID: 25004281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptom profiles, cardio-metabolic risk and inflammation: Results from the MIDUS study.
    Chirinos DA; Murdock KW; LeRoy AS; Fagundes C
    Psychoneuroendocrinology; 2017 Aug; 82():17-25. PubMed ID: 28486177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of depression heterogeneity using proteomic clusters.
    van Haeringen M; Milaneschi Y; Lamers F; Penninx BWJH; Jansen R
    Psychol Med; 2023 May; 53(7):2904-2912. PubMed ID: 35039097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between systemic inflammation and somatic depressive symptoms: Findings from the Moli-sani study.
    Gialluisi A; Di Castelnuovo A; Bracone F; De Curtis A; Cerletti C; Donati MB; de Gaetano G; Iacoviello L
    Depress Anxiety; 2020 Sep; 37(9):935-943. PubMed ID: 32627260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-analysis of symptom clusters in advanced cancer patients attending a palliative outpatient radiotherapy clinic.
    McKenzie E; Zhang L; Zaki P; Chan S; Ganesh V; Razvi Y; Tsao M; Barnes E; Hwang MK; DeAngelis C; Chow E
    Ann Palliat Med; 2019 Apr; 8(2):140-149. PubMed ID: 30525764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure.
    Naudé PJ; Mommersteeg PM; Gouweleeuw L; Eisel UL; Denollet J; Westerhuis LW; Schoemaker RG
    World J Biol Psychiatry; 2015 Oct; 16(7):536-41. PubMed ID: 26212793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts.
    Milaneschi Y; Kappelmann N; Ye Z; Lamers F; Moser S; Jones PB; Burgess S; Penninx BWJH; Khandaker GM
    Mol Psychiatry; 2021 Dec; 26(12):7393-7402. PubMed ID: 34135474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort.
    Chu AL; Stochl J; Lewis G; Zammit S; Jones PB; Khandaker GM
    Brain Behav Immun; 2019 Feb; 76():74-81. PubMed ID: 30414442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA).
    Prather AA; Vogelzangs N; Penninx BW
    J Psychiatr Res; 2015 Jan; 60():95-102. PubMed ID: 25307717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression severity is associated with increased inflammation in veterans with peripheral artery disease.
    Hernandez NV; Ramirez JL; Khetani SA; Spaulding KA; Gasper WJ; Hiramoto J; Lindqvist D; Wolkowitz OM; Hills NK; Grenon SM; Zahner GJ
    Vasc Med; 2018 Oct; 23(5):445-453. PubMed ID: 30035700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.